세계의 마이크로카테터 시장 : 기회와 촉진요인, 산업 동향 분석 예측(2024-2032년)

The Global Microcatheters Market was valued at USD 985.5 million in 2023 and is projected to grow at a CAGR of 5.1% from 2024 to 2032. This growth is largely fueled by rising demand for minimally invasive surgical procedures and technological advancements in catheters. The surge in minimally invasive surgical procedures is a primary catalyst for the market expansion. These surgeries have gained traction due to their advantages over traditional open surgeries, such as quicker recovery times, reduced complication risks, less pain and scarring, and shorter hospital stays. Consequently, there has been a pronounced shift towards minimally invasive surgeries (MIS) across diverse medical fields, including neurology, cardiology, oncology, and peripheral vascular treatments.

The industry is divided into product, design, application, end-use, and region. The market segments products into delivery microcatheters, diagnostic microcatheters, aspiration microcatheters, and steerable microcatheters. Notably, the steerable segment is projected to grow the fastest, at a 5.3% CAGR. This surge is attributed to their rising use in cardiovascular angiography, where they offer enhanced success rates and shorter procedural times compared to standard microcatheters.

Their unique feature allows real-time angulation adjustments, boosting the efficiency of super-selective vessel cannulation. Applications of microcatheters span cardiovascular, neurovascular, peripheral vascular, oncology, and more. The cardiovascular segment dominated the market, raking in approximately USD 401.2 million in 2023. This prominence is largely due to the escalating global incidence of cardiovascular disorders (CVDs). The World Health Organization (WHO) highlights the gravity, noting CVDs as the top global death cause, accounting for over 30% of all deaths.In 2023, North America generated a substantial USD 331.4 million in microcatheter revenue. This robust figure is driven by a rising prevalence of neurovascular and cardiovascular diseases and an uptick in percutaneous coronary intervention procedures. Furthermore, bolstering this growth are government initiatives, a network of established healthcare facilities, and the ready availability of advanced technological products.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing number of minimally invasive surgical procedures
    • 3.2.1.2 Increasing number of patients suffering from chronic diseases
    • 3.2.1.3 Technological advancements
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High risk and complexity associated with microcatheters
• 3.3 Growth potential analysis
• 3.4 Regulatory scenario
• 3.5 Technology landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Future market trends
• 3.9 Reimbursement scenario
• 3.10 Gap analysis
• 3.11 Pricing analysis, 2023
• 3.12 Value chain analysis
• 3.13 Ecosystem mapping

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Delivery microcatheter
• 5.3 Diagnostic microcatheter
• 5.4 Aspiration microcatheter
• 5.5 Steerable microcatheter

Chapter 6 Market Estimates and Forecast, By Design, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Single lumen microcatheter
• 6.3 Dual lumen microcatheter

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Cardiovascular
• 7.3 Neurovascular
• 7.4 Peripheral vascular
• 7.5 Oncology
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Acrostak
• 10.2 Asahi Intecc USA, Inc.
• 10.3 Boston Scientific Corporation
• 10.4 Cardiovascular Systems, Inc (Abbott Laboratories, Inc.)
• 10.5 Cook Medical
• 10.6 Embolx, Inc.
• 10.7 Integer Holdings Corporation
• 10.8 Medtronic plc
• 10.9 Merit Medical System, Inc.
• 10.10 Penumbra, Inc.
• 10.11 Reflow Medical, Inc.
• 10.12 Stryker Corporation
• 10.13 Teleflex Corporation
• 10.14 Terumo Corporation
• 10.15 Transit Scientific